BUILD-IN PAGE COMPOSER

WBN (Worldwide Broker Network) in June 2017 announced the addition of Pacific Prime as its latest member. Pacific Prime is a brokerage firm headquartered in Hong Kong, and a growing international health insurance advisor and property & casualty broker that leverages its close relationships with over 60 insurance companies. Founded in 1999 by Neil Raymond, Pacific Prime employs more than 400 staff including 35 nationalities. Raymond began his working career at Shell

TRAVEL

BEAUTY

HIPSTER

Latest Posts

Inge Vanderreken inge.vanderreken@allenovery.com Allen & Overy belgium Partner Inge specialises in the full range of law involving employment, employee benefits and incentives. Being an active member of Allen & Overy’s Global Employment & Benefits Group, she regularly advises on multi-jurisdictional employment matters. A strong focus of her work is the advice on matters in relation with restructurings, outsourcings and HR-compliance with whistleblowing currently being a key topic. She has

Markulf Behrendt markulf.behrendt@allenovery.com Allen & Overy Hamburg, Germany Partner, Global Head of Employment & Benefits Markulf’s combination of extensive experience in employment law, regular advice to leading B2C companies on complex proceedings, and his lecturing and speaking engagements on human resources issues, keep him at the cutting edge of his field. He holds several key management roles such as Global Head of Employment & Benefits and Co-head of the

Camille Wattrelos camille.wattrelos@allenovery.com Allen & Overy France Employment & Benefits Associate Camille Wattrelos is an associate in the Paris employment law department. She advises French and foreign companies on labour, employment and social security law issues, including employee representative bodies, working time, international mobility and savings schemes. She also provides assistance to clients in relation to restructurings as well as on litigation matters. Having studied law in Paris and

The heart rate monitor built into the new Apple Watch has sparked sharp debate over its risks and benefits, even though the feature was cleared by the Food and Drug Administration. But out of the spotlight, the FDA has been doing away with regulatory action altogether on many diagnostic health apps targeting consumers, seeking to accelerate digital health adoption by defining many of these as “low risk” medical devices.
SHARE

Sample Home 1